psychosis | CARLAT PUBLISHING

BOOK REVIEWS FOR PSYCHIATRISTS

Using Stories to Color the Stark Lines of Evidence-Based Medicine: Elyn R. Saks

February 9, 2023

Emily E. Whisler, DO and Edmund S. Higgins, MD.

The first in a series of interesting reading for psychiatrists

RESEARCH UPDATE

Aripiprazole-Related Psychotic Exacerbations

January 1, 2023

Brian Miller, MD, PhD, MPH.

Brian Miller, MD, PhD, MPH. Dr. Miller, author of this educational activity, receives research support from Augusta University, the National Institute of Mental Health, the Brain and Behavior Research Foundation, and the Stanley Medical Research Institute. Relevant financial relationships listed for the author have been mitigated.

This study identifies a common clinical scenario where aripiprazole may trigger psychotic symptoms.

CLINICAL UPDATE

Who's Who? A Review of Delusional Misidentification Syndromes

October 1, 2022

Adrienne Grzenda, MD, PhD.

Adrienne Grzenda, MD. Clinical Assistant Professor of Psychiatry & Biobehavioral Sciences, UCLA David Geffen School of Medicine and Olive View UCLA Medical Center, Los Angeles, CA. Dr. Grzenda, author for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

You have probably encountered patients who adamantly insist a loved one has been replaced by an impostor. Here are tips for how to treat them.

RESEARCH UPDATE

Can Pimavanserin Treat Psychosis in Patients With Dementia?

October 1, 2022

James Black, MD

James Black, MD. Dr. Black, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

This study suggests that patients started on pimavanserin for dementia and psychosis should probably continue it to prevent relapse, but we will need more data for clarity given flaws in the study design.

10 Psychopharm Commandments #1

September 5, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Antidepressants in mania and stimulants in psychotic disorders get called out in our first psychopharm commandment.

Psychosis During Depression

August 23, 2022

Conrad M. Swartz, MD, PhD

Conrad M. Swartz, MD, PhD. Professor Emeritus, Southern Illinois University, Springfield, IL. Dr. Swartz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Psychotic depression is difficult to detect, and antipsychotics are not as effective in this condition as we’d like to think. Conrad Swartz explains why 1 in 3 cases of psychotic depression are missed, its complex relationship to trauma, and how to treat it.

EXPERT Q&A

Raising the Bar in Schizophrenia Treatment

January 31, 2022

Brian Miller, MD, PhD, MPH

Brian Miller, MD, PhD, MPH Professor of Psychiatry at the Medical College of Georgia, Augusta, and President of the Georgia Psychiatric Physicians Association. Dr. Miller receives research support from Augusta University, the National Institute of Mental Health, the Brain and Behavior Research Foundation, and the Stanley Medical Research Institute.

Dr. Miller discusses new options for negative symptoms, how to improve the therapeutic alliance, and what to do when clozapine doesn’t work in schizophrenia.

RESEARCH UPDATE

Antipsychotics for Methamphetamine Psychosis

January 18, 2022

Sanya Virani, MD.

Sanya Virani, MD. Dr. Virani has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this network meta-analysis, researchers compared different antipsychotics head-to-head for the treatment of methamphetamine psychosis and found some clear winners are losers.

Medications to Rapidly Treat Psychotic Agitation

September 13, 2021

Victoria Hendrick, MD. and Daniel Carlat, MD

Victoria Hendrick, MD. Editor in Chief, The Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.

Daniel Carlat, MD. Publisher, The Carlat Hospital Psychiatry Report.

Dr. Hendrick and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How do you choose medications to calm an acutely psychotic and agitated patient? We'll tell you which ones are the safest and most effective.

Anti-NMDA Receptor Encephalitis or New-Onset Psychosis?

July 14, 2021

Alex Thompson, MD.

Alex Thompson, MD. Dr. Thompson has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

A type of autoimmune encephalitis causes agitation and psychosis, especially in young women.